| Autor: |
Ribi, E., Parker, R., Strain, S. M., Mizuno, Y., Nowotny, A., Eschen, K. B., Cantrell, J. L., McLaughlin, C. A., Hwang, K. M., Goren, M. B. |
| Zdroj: |
Cancer Immunology, Immunotherapy; October 1979, Vol. 7 Issue: 1 p43-58, 16p |
| Abstrakt: |
The transplantable line-10 hepatocellular carcinoma of guinea-pigs has been used as a model for the study of immunotherapy of malignant tumors. Cure rates of up to 100% have been obtained with ReGl-CM from 0 antigen-deficient (Re) mutant strains of Enterobacteriaceae, provided they were combined with mycobacterial trehalose dimycolate (cord factor, P3). Whereas highly endotoxic LPS extracts from all wild-type strains so far tested have failed to cause tumor regression, acid hydrolysis of such LPS samples led to residual fractions (RESI) that cross-reacted serologically with ReGl-CM samples (Chang and Nowotny, 1975) and provided cure rates up to 100%. RESI from Serratia marcescens was essentially nonpyrogenic and 100 times less lethal for chick embryos than potent endotoxins. Antigenic material associated with endotoxic extracts appears to be cryptic or sterically hindered from being effective in wild-type LPS but is exposed in ReGl and RESI samples. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full text from SpringerLink